Sachem Head Capital Management LP Elanco Animal Health Inc Transaction History

Sachem Head Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$11.49 - $13.65 $290 Million - $344 Million	-25,212,822 Reduced 88.05%	3,422,678 $41.8 Million
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $9.93 Million - $25.9 Million	800,000 Added 2.87%	28,635,500 $355 Million
Q4 2020 Feb 12, 2021	BUY	$27.53 - $33.79 $670 Million - $822 Million	24,335,500 Added 695.3%	27,835,500 $854 Million
Q3 2020 Nov 13, 2020	BUY	$21.1 - $29.13 $73.9 Million - $102 Million	3,500,000 New	3,500,000 $97.8 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Sachem Head Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Sachem Head Capital Management LP with notifications on news.